Eli Lilly (LLY) stock in focus as the company launches Mounjaro Kwikpen in India, intensifying competition with Novo ...

Eli Lilly has launched pre-filled injector pens of its blockbuster weight-loss drug, Mounjaro, giving more options for those ...

Lilly said in June it received approval from India’s drug regulator for its once-weekly Mounjaro Kwikpen, two days after Novo ...

In a phase 3 trial, the daily GLP-1 pill has shown "meaningful weight loss" and similar side effects to injectable GLP-1 drugs like Ozempic, Eli Lilly has said., Health, Times Now ...

Lupin launches Glucagon for Injection USP in emergency kit, bioequivalent to Eli Lilly's product, with $122M annual sales.

Hyderabad: Sales of weight-loss drugs Wegovy by Danish pharmaceutical giant Novo Nordisk and Mounjaro by U.S.-based Eli Lilly ...

In July 2025 alone, Wegovy clocked Rs 7 crore in sales with around 5,000 injections, while Mounjaro posted Rs 47 crore in ...

Eli Lilly reports strong Q2 2025 growth, driven by Mounjaro & Zepbound. Highlights include increased guidance, pipeline updates, and key clinical milestones.

Sales of Danish drugmaker Novo Nordisk 's Wegovy and U.S. rival Eli Lilly's Mounjaro in India doubled in July from a month ...

India's Divi's Laboratories reported first-quarter profit below estimates on Wednesday, as manufacturers producing generic ...

Hyderabad: Ina major boost to Telangana’s life sciences and innovation ecosystem, global pharmaceutical giant Eli Lilly ...

Hyderabad: Eli Lilly and Company (India) has announced the opening of its new technology and innovation site in Hyderabad; a ...